| Attributes | Values |
|---|
| rdf:type
| |
| Description
| - In 151 immunocompromised patients (haematological malignancies with pulmonary disease) bronchoalveolar fluid was examined obtained with bronchoalveolar lavage. In 124 (82.1 %) patinets this contributed to the determination of the etiology of pulmonary disease, we changed or started treatment in 111 (73.5 %) patients and the validity of ongoing therapy was confirmed in 12 (7.9 %) patients. Treatment with antibiotics was started or changed in 79 (52.3 %) patients, with antimycotics in 36 (23.8 %), with antituberculotics in 2 (1.3 %), and with virostatics in 19 (12.6 %) patients; antipneumocystic treatment was started in 19 (12.6 %) patients. In 25 (16.6 %) patients the cytostatic treatment was started or changed. Bronchoalveolar lavage and examination of bronchoalveolar fluid contributed substantially to the diagnostics of pulmonary, chiefly infectious diseases in immunocompromised patients.
- In 151 immunocompromised patients (haematological malignancies with pulmonary disease) bronchoalveolar fluid was examined obtained with bronchoalveolar lavage. In 124 (82.1 %) patinets this contributed to the determination of the etiology of pulmonary disease, we changed or started treatment in 111 (73.5 %) patients and the validity of ongoing therapy was confirmed in 12 (7.9 %) patients. Treatment with antibiotics was started or changed in 79 (52.3 %) patients, with antimycotics in 36 (23.8 %), with antituberculotics in 2 (1.3 %), and with virostatics in 19 (12.6 %) patients; antipneumocystic treatment was started in 19 (12.6 %) patients. In 25 (16.6 %) patients the cytostatic treatment was started or changed. Bronchoalveolar lavage and examination of bronchoalveolar fluid contributed substantially to the diagnostics of pulmonary, chiefly infectious diseases in immunocompromised patients. (en)
- In 151 immunocompromised patients (haematological malignancies with pulmonary disease) bronchoalveolar fluid was examined obtained with bronchoalveolar lavage. In 124 (82.1 %) patinets this contributed to the determination of the etiology of pulmonary disease, we changed or started treatment in 111 (73.5 %) patients and the validity of ongoing therapy was confirmed in 12 (7.9 %) patients. Treatment with antibiotics was started or changed in 79 (52.3 %) patients, with antimycotics in 36 (23.8 %), with antituberculotics in 2 (1.3 %), and with virostatics in 19 (12.6 %) patients; antipneumocystic treatment was started in 19 (12.6 %) patients. In 25 (16.6 %) patients the cytostatic treatment was started or changed. Bronchoalveolar lavage and examination of bronchoalveolar fluid contributed substantially to the diagnostics of pulmonary, chiefly infectious diseases in immunocompromised patients. (cs)
|
| Title
| - The use of bronchoalveolar lavage in diagnosis of infectious pulmonary complications in immunocompromised patients.
- The use of bronchoalveolar lavage in diagnosis of infectious pulmonary complications in immunocompromised patients. (en)
- The use of bronchoalveolar lavage in diagnosis of infectious pulmonary complications in immunocompromised patients. (cs)
|
| skos:prefLabel
| - The use of bronchoalveolar lavage in diagnosis of infectious pulmonary complications in immunocompromised patients.
- The use of bronchoalveolar lavage in diagnosis of infectious pulmonary complications in immunocompromised patients. (en)
- The use of bronchoalveolar lavage in diagnosis of infectious pulmonary complications in immunocompromised patients. (cs)
|
| skos:notation
| - RIV/00216224:14110/00:00005994!RIV08-MSM-14110___
|
| http://linked.open.../vavai/riv/strany
| |
| http://linked.open...avai/riv/aktivita
| |
| http://linked.open...avai/riv/aktivity
| |
| http://linked.open...iv/cisloPeriodika
| |
| http://linked.open...vai/riv/dodaniDat
| |
| http://linked.open...aciTvurceVysledku
| |
| http://linked.open.../riv/druhVysledku
| |
| http://linked.open...iv/duvernostUdaju
| |
| http://linked.open...titaPredkladatele
| |
| http://linked.open...dnocenehoVysledku
| |
| http://linked.open...ai/riv/idVysledku
| - RIV/00216224:14110/00:00005994
|
| http://linked.open...riv/jazykVysledku
| |
| http://linked.open.../riv/klicovaSlova
| - Immunocompromised patient - pulmonary infection - bronchoscopy - bronchoalveolar lavage - bronchoalveolar fluid (en)
|
| http://linked.open.../riv/klicoveSlovo
| |
| http://linked.open...odStatuVydavatele
| |
| http://linked.open...ontrolniKodProRIV
| |
| http://linked.open...i/riv/nazevZdroje
| - Journal of Health Management and Public Health
|
| http://linked.open...in/vavai/riv/obor
| |
| http://linked.open...ichTvurcuVysledku
| |
| http://linked.open...cetTvurcuVysledku
| |
| http://linked.open...UplatneniVysledku
| |
| http://linked.open...v/svazekPeriodika
| |
| http://linked.open...iv/tvurceVysledku
| - Mayer, Jiří
- Skřičková, Jana
- Ševčíková, Alena
- Vorlíček, Jiří
- Votava, Miroslav
- Merta, Zdeněk
- Špelda, Stanislav
- Burgetová, Dagmar
- Kubálek, Vojtěch
- Mezenský, Lev
- Drašar, V.
- Kunderová, H.
- Štroblová, H.
|
| http://linked.open...n/vavai/riv/zamer
| |
| issn
| |
| number of pages
| |
| http://localhost/t...ganizacniJednotka
| |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)